Study: NCT02040766

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate BAI
Description: Beclomethasone dipropionate (BDP), was delivered by a single inhalation using a breath-actuated inhaler (BAI) at levels of 40 mcg or 80 mcg per inhalation, twice each day.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate BAI
Description: Beclomethasone dipropionate (BDP), was delivered by a single inhalation using a breath-actuated inhaler (BAI) at levels of 40 mcg or 80 mcg per inhalation, twice each day.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo BAI
Description: Placebo was delivered by a single inhalation using a breath-actuated inhaler (BAI) twice each day.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo BAI
Description: Placebo was delivered by a single inhalation using a breath-actuated inhaler (BAI) twice each day.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo BAI
Description: Placebo was delivered by a single inhalation using a breath-actuated inhaler (BAI) twice each day.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: albuterol/salbutamol 90 mcg
Description: Rescue medication (albuterol/salbutamol hydrofluoroalkane (HFA) MDI \[90 mcg ex-actuator\] or equivalent) for use on an as-needed basis for the immediate relief of asthma symptoms throughout the treatment period.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: albuterol/salbutamol 90 mcg
Description: Rescue medication (albuterol/salbutamol hydrofluoroalkane (HFA) MDI \[90 mcg ex-actuator\] or equivalent) for use on an as-needed basis for the immediate relief of asthma symptoms throughout the treatment period.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: albuterol/salbutamol 90 mcg
Description: Rescue medication (albuterol/salbutamol hydrofluoroalkane (HFA) MDI \[90 mcg ex-actuator\] or equivalent) for use on an as-needed basis for the immediate relief of asthma symptoms throughout the treatment period.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: albuterol/salbutamol 90 mcg
Description: Rescue medication (albuterol/salbutamol hydrofluoroalkane (HFA) MDI \[90 mcg ex-actuator\] or equivalent) for use on an as-needed basis for the immediate relief of asthma symptoms throughout the treatment period.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: albuterol/salbutamol 90 mcg
Description: Rescue medication (albuterol/salbutamol hydrofluoroalkane (HFA) MDI \[90 mcg ex-actuator\] or equivalent) for use on an as-needed basis for the immediate relief of asthma symptoms throughout the treatment period.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Beclomethasone dipropionate MDI
Description: Beclomethasone dipropionate (BDP), was delivered by a single inhalation using a metered-dose inhaler (MDI) at levels of 40 mcg or 80 mcg per inhalation, twice each day.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Beclomethasone dipropionate MDI
Description: Beclomethasone dipropionate (BDP), was delivered by a single inhalation using a metered-dose inhaler (MDI) at levels of 40 mcg or 80 mcg per inhalation, twice each day.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo MDI
Description: Placebo was delivered by a single inhalation using a metered-dose inhaler (MDI) twice each day.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo MDI
Description: Placebo was delivered by a single inhalation using a metered-dose inhaler (MDI) twice each day.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo MDI
Description: Placebo was delivered by a single inhalation using a metered-dose inhaler (MDI) twice each day.